Follow-The-Filings

Security · featured owners

IRON Disc Medicine Inc.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 2 Owners
  • Max 5.7%
  • $93M
  • 2 add

IRON (Disc Medicine Inc.) is held in 2 featured 13F books as of 2026 Q2. James Silverman - Opaleye Management is the largest tracked holder by portfolio weight (5.7%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 5.7% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman add 5.7%
  2. Palo Alto Investors add 4.2%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 5.7% Add +103.1% 855,000 $63M history
Palo Alto Investors 2026 Q2 4.2% Add +3.7% 416,646 $30M history

2 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 11 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,8.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
8-K 2.05 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 15 rows shown

Filed Form Detail Links
4 Period Sep 15, 2026 Filing Doc
4 Period Sep 11, 2026 Filing Doc
4 Period Sep 4, 2026 Filing Doc
4 Period Sep 1, 2026 Filing Doc
4 Period Aug 24, 2026 Filing Doc
4 Period Aug 17, 2026 Filing Doc
4 Period Aug 12, 2026 Filing Doc
4 Period Aug 6, 2026 Filing Doc
4 Period Jul 13, 2026 Filing Doc
4 Period Jul 7, 2026 Filing Doc
4 Period Jun 26, 2026 · 2 forms Filing Doc
4 Period Jun 22, 2026 Filing Doc
4 Period Jun 18, 2026 · 9 forms Filing Doc
4 Period Jun 16, 2026 Filing Doc
4 Period Apr 13, 2026 · 2 forms Filing Doc

Updated about 10 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$76.43M -$109.36M -$212.18M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $365.66M $493.62M $803.9M
Total non-current assets * $2.33M $3.16M $2.98M
Total assets $368M $496.77M $806.88M
Total current liabilities $21.44M $23.32M $36.64M
Total non-current liabilities * $1.44M $29.87M $30.41M
Total equity $345.12M $443.59M $739.83M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$73.46M -$93.93M -$180.39M
Cash from investing -$0.089M -$292.33M -$394.3M
Cash from financing $239.38M $218.31M $473.41M
Net change in cash $165.83M -$167.94M -$101.28M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders